Implications of Using Different Methods to Characterise Anticoagulant Control in Patients with Second Generation Mechanical Heart Valve Prostheses

Open Access

Peer-reviewed

Research Article

Francesca Fiorentino,

Affiliation National Heart & Lung Institute, Imperial College London, Hammersmith Hospital, London, United Kingdom
⨯
Chris A. Rogers,

Affiliation Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol, United Kingdom
⨯
Alan J. Bryan,

Affiliation Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol, United Kingdom
⨯
Gianni D. Angelini,

Affiliations Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol, United Kingdom, National Heart & Lung Institute, Imperial College London, Hammersmith Hospital, London, United Kingdom
⨯
Barnaby C. Reeves

* E-mail: barney.reeves@bristol.ac.uk

Affiliation Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol, United Kingdom
⨯

Reader Comments (0)

Anticoagulants
Is the Subject Area "Anticoagulants" applicable to this article?

Thanks for your feedback.
Hemorrhage
Is the Subject Area "Hemorrhage" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Randomized controlled trials
Is the Subject Area "Randomized controlled trials" applicable to this article?

Thanks for your feedback.
Thromboembolism
Is the Subject Area "Thromboembolism" applicable to this article?

Thanks for your feedback.
Heart
Is the Subject Area "Heart" applicable to this article?

Thanks for your feedback.
Measurement
Is the Subject Area "Measurement" applicable to this article?

Thanks for your feedback.
Prosthetics
Is the Subject Area "Prosthetics" applicable to this article?

Thanks for your feedback.